Buy Antiandrogen 427-51-0 Cyproterone Acetate For Prostate Cancer , Antiandrogen 427-51-0 Cyproterone Acetate For Prostate Cancer Suppliers, Manufacturers, Traders








Antiandrogen 427-51-0 Cyproterone Acetate For Prostate Cancer Suppliers

antiandrogen 427-51-0 cyproterone acetate for prostate cancer

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
Antiandrogen 427-51-0 Cyproterone Acetate For Prostate Cancer
 
Cyproterone Acetate Basic Info.:
 
Product Name: Cyproterone acetate
CAS: 427-51-0
MF: C24H29ClO4
MW: 416.94
EINECS: 207-048-3
Melting Point: 200-201°C
Boiling Point: 525.9oC at 760 mmHg
Flash Point: 177.6°C
Storage Temp.: 2-8°C
Appearance: Crystalline Solid
Manufacturer: Kafen
Product Categories: Antibiotics;Steroids;Intermediates & Fine Chemicals;Pharmaceuticals;Intracellular receptor;Steroid and Hormone;VETRANAL;Hormone Drugs.
Usage: The free alcohol is an anti-androgen; The acetate is both an anti-androgen and a progestogen. Combined with estrogen it is used in the treatment of acne. 
 
Cyproterone Acetate Description:
 
Cyproterone acetate (INN, USAN, BAN, JAN), sometimes abbreviated asnCPA, and sold under brand names such as Androcur and Cyprostat, isna synthetic steroidal antiandrogen drug with additional progestogennand antigonadotropic.
The main therapeutic indications ofncyproterone acetate are prostate cancer, benign prostaticnhyperplasia, priapism, hypersexuality (e.g., as a form of chemicalncastration), and other conditions in which androgen actionnmaintains the disease process.
 
Cyproterone Acetate Application:
 
CPA has been in use as an antiandrogen since 1964, and was the first antiandrogen introduced for clinical use.It is widely used throughout Europe, and is also used in Canada, Mexico, and other countries. It is not FDA-approved for use in the United States.
due to concerns about hepatotoxicity;medroxyprogesterone acetate has been used in this country instead.CPA has been approved for the treatment of prostate cancer, precocious puberty, androgen-related dermatological conditions (such as acne, seborrhea, hirsutism, and androgenic alopecia), and to reduce sex drive in sex offenders.
Combination formulations of CPA with ethinyl estradiol (a formulation sometimes referred to as co-cyprindiol) have been available as contraceptives since 1997.Other uses of CPA include the treatment of benign prostatic hyperplasia, priapism, hypersexuality, paraphilias, hot flashes, and hyperandrogenism in women. In addition, with the exception of the United States (where CPA is not available and spironolactone is generally employed instead), CPA is widely used as a component of hormone replacement therapy.
 
CAS Number:427-51-0
Appearance: whatsapp: +8618002259573

Guangzhou Kafen Biotech Co.,Ltd.

No.128,Hanxing East Rd, Zhongcun, Panyu District, Guangzhou, Guangdong, China, guangzhou, china

china china

Antiandrogen Antiandrogen
antiandrogen 427-51-0 cyproterone acetate for prostate cancer

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
Antiandrogen 427-51-0 Cyproterone Acetate For Prostate Cancer
 
Cyproterone Acetate Basic Info.:
 
Product Name: Cyproterone acetate
CAS: 427-51-0
MF: C24H29ClO4
MW: 416.94
EINECS: 207-048-3
Melting Point: 200-201°C
Boiling Point: 525.9oC at 760 mmHg
Flash Point: 177.6°C
Storage Temp.: 2-8°C
Appearance: Crystalline Solid
Manufacturer: Kafen
Product Categories: Antibiotics;Steroids;Intermediates & Fine Chemicals;Pharmaceuticals;Intracellular receptor;Steroid and Hormone;VETRANAL;Hormone Drugs.
Usage: The free alcohol is an anti-androgen; The acetate is both an anti-androgen and a progestogen. Combined with estrogen it is used in the treatment of acne. 
 
Cyproterone Acetate Description:
 
Cyproterone acetate (INN, USAN, BAN, JAN), sometimes abbreviated asnCPA, and sold under brand names such as Androcur and Cyprostat, isna synthetic steroidal antiandrogen drug with additional progestogennand antigonadotropic.
The main therapeutic indications ofncyproterone acetate are prostate cancer, benign prostaticnhyperplasia, priapism, hypersexuality (e.g., as a form of chemicalncastration), and other conditions in which androgen actionnmaintains the disease process.
 
Cyproterone Acetate Application:
 
CPA has been in use as an antiandrogen since 1964, and was the first antiandrogen introduced for clinical use.It is widely used throughout Europe, and is also used in Canada, Mexico, and other countries. It is not FDA-approved for use in the United States.
due to concerns about hepatotoxicity;medroxyprogesterone acetate has been used in this country instead.CPA has been approved for the treatment of prostate cancer, precocious puberty, androgen-related dermatological conditions (such as acne, seborrhea, hirsutism, and androgenic alopecia), and to reduce sex drive in sex offenders.
Combination formulations of CPA with ethinyl estradiol (a formulation sometimes referred to as co-cyprindiol) have been available as contraceptives since 1997.Other uses of CPA include the treatment of benign prostatic hyperplasia, priapism, hypersexuality, paraphilias, hot flashes, and hyperandrogenism in women. In addition, with the exception of the United States (where CPA is not available and spironolactone is generally employed instead), CPA is widely used as a component of hormone replacement therapy.
 
CAS Number:427-51-0
Appearance: whatsapp: +8618002259573